Australia Approves World-First Vaccine To Save Koalas From Chlamydia
Developed over more than 10 years by Australia's University of the Sunshine Coast (UniSC), the vaccine's approval by the Australian Pesticides and Veterinary Medicines Authority marks a major step to protect endangered koalas from chlamydia infection and death, according to a UniSC statement released on Wednesday.
The disease, spread through breeding, can cause painful urinary tract infections, infertility, blindness and even death, with infection rates reaching as high as 70 per cent in some cases, the statement said.
A UniSC-led study found the vaccine reduced the likelihood of koalas developing symptoms of chlamydia during breeding age and decreased mortality from the disease in wild populations by at least 65 per cent.
The single-dose vaccine was cleared by the veterinary medicine regulator for use in wildlife hospitals, veterinary clinics and in the field, UniSC Professor of Microbiology Peter Timms said.
"We knew a single-dose vaccine, with no need for a booster, was the answer to reducing the rapid, devastating spread of this disease, which accounts for as much as half of koala deaths across all wild populations in Australia," he said.
Until now, antibiotics were the only treatment available for koalas infected with chlamydia, but they can disrupt a koala's ability to digest eucalyptus leaves, its sole source of food, leading to starvation and, in some cases, death. They also often fail to prevent future infection, Xinhua news agency reported.
A decade of clinical data, gathered through multiple vaccination trials, confirmed the vaccine's safety and effectiveness, according to the statement.
Chlamydia is one of the most common sexually transmitted infections (STIs). You can get chlamydia from intercourse, anal sex or oral sex. Because chlamydia often doesn't cause symptoms, many people who have chlamydia don't know it and unknowingly infect other people. Regular screenings can help reduce the spread.
Chlamydia is the most common STI caused by bacteria. About 1.5 million cases of chlamydia are reported each year. The number of infections is likely even higher. Most cases of chlamydia are asymptomatic, which means there are no signs or symptoms of an infection. Many of these cases likely go unreported.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Japan Buy Now Pay Later Market Size To Surpass USD 145.5 Billion By 2033 CAGR Of 22.23%
- BTCC Summer Festival 2025 Unites Japan's Web3 Community
- GCL Subsidiary, 2Game Digital, Partners With Kucoin Pay To Accept Secure Crypto Payments In Real Time
- Smart Indoor Gardens Market Growth: Size, Trends, And Forecast 20252033
- Nutritional Bar Market Size To Expand At A CAGR Of 3.5% During 2025-2033
- Pluscapital Advisor Empowers Traders To Master Global Markets Around The Clock
Comments
No comment